Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2007-7-19
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0887-6924
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1843-5
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17443220-Adolescent, pubmed-meshheading:17443220-Adult, pubmed-meshheading:17443220-Aged, pubmed-meshheading:17443220-Aged, 80 and over, pubmed-meshheading:17443220-Chromosomes, Human, Pair 21, pubmed-meshheading:17443220-Chromosomes, Human, Pair 8, pubmed-meshheading:17443220-DNA, Neoplasm, pubmed-meshheading:17443220-DNA Mutational Analysis, pubmed-meshheading:17443220-Female, pubmed-meshheading:17443220-Humans, pubmed-meshheading:17443220-Janus Kinase 2, pubmed-meshheading:17443220-Leukemia, Myeloid, Acute, pubmed-meshheading:17443220-Male, pubmed-meshheading:17443220-Middle Aged, pubmed-meshheading:17443220-Mutation, pubmed-meshheading:17443220-Myeloproliferative Disorders, pubmed-meshheading:17443220-Translocation, Genetic, pubmed-meshheading:17443220-Trisomy, pubmed-meshheading:17443220-Tumor Markers, Biological
pubmed:year
2007
pubmed:articleTitle
JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.
pubmed:publicationType
Journal Article